Cigna Settles FTC Insulin Case, Commits to Drug Pricing Overhaul

Cigna Corp.’s Express Scripts has settled the U.S. Federal Trade Commission’s claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies, according to a copy …

Read the full article →

Share:

More Posts

Send Us A Message